Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideki Ohminami is active.

Publication


Featured researches published by Hideki Ohminami.


Journal of General Virology | 1998

APOPTOSIS OF CD4+ T LYMPHOCYTES IN HUMAN HERPESVIRUS-6 INFECTION

Masaki Yasukawa; Yasuhiro Inoue; Hideki Ohminami; Kihei Terada; Shigeru Fujita

The present authors have recently reported that inoculation with human herpesvirus-6 (HHV-6) renders CD4+ T lymphocytes susceptible to apoptosis in vitro. In order to confirm that apoptosis of CD4+ T lymphocytes also occurs in HHV-6 infection in vivo, apoptosis of lymphocytes isolated from nine patients with exanthem subitum and from an adult patient with severe HHV-6 infection was examined. Peripheral blood mononuclear cells were cultured for 3 days and apoptosis of lymphocytes was then examined by flow cytometry of propidium iodide-stained DNA. The percentages of hypodiploid DNA, indicating apoptosis, in lymphocytes from 10 patients with HHV-6 infection were significantly higher than those from five infant patients with noninfectious diseases and five healthy adults (P < 0-0002). DNA fragmentation was also detected by agarose gel electrophoresis in lymphocytes from patients with HHV-6 infection. Apoptosis appeared to occur predominantly in CD4+ T lymphocytes and HHV-6 was isolated from the CD4+ T lymphocyte fraction. These data demonstrate that HHV-6 renders CD4+ T lymphocytes susceptible to apoptosis in vivo.


American Journal of Hematology | 1998

Neoplastic involvement of granulocytic lineage, not granulocytic-monocytic, monocytic, or erythrocytic lineage, in a patient with chronic neutrophilic leukemia case report

Kohsuke Yanagisawa; Hideki Ohminami; Masateru Sato; Kiyonori Takada; Hitoshi Hasegawa; Masaki Yasukawa; Shigeru Fujita

Chronic neutrophilic leukemia (CNL) is a very rare myeloproliferative disorder. To determine the neoplastic origin of CNL, morphological and cytogenetical studies were made of colonies derived from hematopoietic progenitors of a patient with CNL. The patients hematopoietic progenitors spontaneously formed colonies consisting of mature granulocytes, and cytogenetical study of the colonies indicated chromosome abnormalities identical to those in the patients bone marrow cells. Analysis of colonies consisting of granulocytes and macrophages, macrophages, or erythrocytes disclosed a normal karyotype. These results demonstrated that the neoplastic process in this patient with CNL originated in hematopoietic progenitors capable of differentiating only into granulocytes, and not granulocytes and monocytes, monocytes, or erythrocytes. Am. J. Hematol. 57:221–224, 1998.


Blood | 2000

HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide

Hideki Ohminami; Masaki Yasukawa; Shigeru Fujita


Blood | 2001

Identification of human telomerase reverse transcriptase–derived peptides that induce HLA-A24–restricted antileukemia cytotoxic T lymphocytes

Junko Arai; Masaki Yasukawa; Hideki Ohminami; Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita


Blood | 2000

Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans

Masaki Yasukawa; Hideki Ohminami; Junko Arai; Yoshihito Kasahara; Yasushi Ishida; Shigeru Fujita


Blood | 1998

CD4(+) cytotoxic T-cell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR-restricted manner.

Masaki Yasukawa; Hideki Ohminami; Shin Kaneko; Yoshihiro Yakushijin; Yasuharu Nishimura; Koiti Inokuchi; Tsuyoshi Miyakuni; Shinji Nakao; Kenji Kishi; Ichiro Kubonishi; Kazuo Dan; Shigeru Fujita


Journal of Immunology | 1999

Fas-Independent Cytotoxicity Mediated by Human CD4 + CTL Directed Against Herpes Simplex Virus-Infected Cells

Masaki Yasukawa; Hideki Ohminami; Yoshihiro Yakushijin; Junko Arai; Atsuhiko Hasegawa; Yasushi Ishida; Shigeru Fujita


Journal of Immunology | 1999

Down-Regulation of CXCR4 by Human Herpesvirus 6 (HHV-6) and HHV-7

Masaki Yasukawa; Atsuhiko Hasegawa; Ikuya Sakai; Hideki Ohminami; Junko Arai; Shin Kaneko; Yoshihiro Yakushijin; Kazutaka Maeyama; Hideki Nakashima; Rieko Arakaki; Shigeru Fujita


Blood | 2001

HLA class II–restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia–derived dendritic cells to CD4+ T lymphocytes

Masaki Yasukawa; Hideki Ohminami; Kensuke Kojima; Takaaki Hato; Atsuhiko Hasegawa; Tsuyoshi Takahashi; Hisamaru Hirai; Shigeru Fujita


Blood | 1999

Fas-Independent and Nonapoptotic Cytotoxicity Mediated by a Human CD4+ T-Cell Clone Directed Against an Acute Myelogenous Leukemia–Associated DEK-CAN Fusion Peptide

Hideki Ohminami; Masaki Yasukawa; Shin Kaneko; Yoshihiro Yakushijin; Yasuhito Abe; Yoshihito Kasahara; Yasushi Ishida; Shigeru Fujita

Collaboration


Dive into the Hideki Ohminami's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atsuhiko Hasegawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge